(Q48464771)

11 February 2018

title

WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex. (English)

1 reference

11 February 2018

0 references

Millan MJ

1

1 reference

11 February 2018

Brocco M

2

1 reference

11 February 2018

Veiga S

3

1 reference

11 February 2018

Cistarelli L

4

1 reference

11 February 2018

Melon C

5

1 reference

11 February 2018

Gobert A

6

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

11 February 2018

European Journal of Pharmacology

published in

1 reference

11 February 2018

volume

341

1 reference

11 February 2018

issue

2-3

1 reference

11 February 2018

page(s)

165-167

1 reference

11 February 2018

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901445-3

Is the forced swimming test a suitable model for revealing antidepressant activity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901445-3

Depression: a new animal model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901445-3

The potent activity of the 5-HT1A receptor agonists, S 14506 and S 14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901445-3

Local 5HT3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901445-3

10.1016/S0014-2999(97)01445-3

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9543235

1 reference

11 February 2018